DIAGNOSTIC CRITERIA FOR ANCA-ASSOCIATED PRIMARY SYSTEMIC VASCULITIS (AASV) IN PATIENTS PRESENTING WITH ACUTE PULMONARY AND/OR RENAL DISEASE

DIAGNOSTIC CRITERIA FOR ANCA-ASSOCIATED PRIMARY SYSTEMIC VASCULITIS (AASV) IN PATIENTS PRESENTING WITH ACUTE PULMONARY AND/OR RENAL DISEASE

Bibliografski detalji
Glavni autori:	McLaren, J, Hall, C, Luqmani, R
Format:	Journal article
Izdano:	2004

Slični predmeti

DEVELOPMENT OF DIAGNOSTIC CRITERIA FOR PRIMARY ANCA-ASSOCIATED SYSTEMIC VASCULITIS (AASV)
od: McLaren, J, i dr.
Izdano: (2003)

Cardiovascular disease incidence and risk factors in ANCA-associated primary systemic vasculitis (AASV)
od: Salisbury, E, i dr.
Izdano: (2003)

CARDIOVASCULAR AND CEREBROVASCULAR DISEASE INCIDENCE AND RISK FACTORS IN ANCA-ASSOCIATED PRIMARY SYSTEMIC VASCULITIS (AASV)
od: Salisbury, E, i dr.
Izdano: (2004)

INCIDENCE OF NON-FATAL CLINICAL CORONARY EVENTS IN PRIMARY ANCA-ASSOCIATED SYSTEMIC VASCULITIS (AASV)
od: Salisbury, E, i dr.
Izdano: (2003)

Incidence of non-fatal clinical coronary events in primary ANCA-associated systemic vasculitis (aasv)
od: Salisbury, E, i dr.
Izdano: (2003)

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
od: McLaren, J, i dr.
Izdano: (2001)

Explaining fatigue in ANCA-associated vasculitis.
od: Basu, N, i dr.
Izdano: (2013)

Explaining fatigue in ANCA-associated vasculitis
od: Basu, N, i dr.
Izdano: (2013)

Towards diagnostic criteria for the ANCA-associated vasculitides.
od: Luqmani, R
Izdano: (2007)

Predictors of renal involvement in ANCA associated vasculitis
od: Kronbichler, A, i dr.
Izdano: (2018)

Damage assessment in ANCA-associated vasculitis.
od: Bhamra, K, i dr.
Izdano: (2012)

Maintenance of clinical remission in ANCA-associated vasculitis.
od: Luqmani, R
Izdano: (2013)

Outcome measures in ANCA-associated vasculitis.
od: Suppiah, R, i dr.
Izdano: (2010)

A four year analysis of variation in use of the anti-neutrophil cytoplasmic antibody (ANCA) test as a screening tool for ANCA-associated systemic vasculitis (AAV) in a teaching hospital.
od: McLaren, J, i dr.
Izdano: (2000)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
od: Jones, R, i dr.
Izdano: (2010)

CONTEXTUALISING QUALITY OF LIFE IN ANCA ASSOCIATED VASCULITIS (AAV)
od: Basu, N, i dr.
Izdano: (2012)

The characterisation and determinants of quality of life in ANCA associated vasculitis.
od: Basu, N, i dr.
Izdano: (2014)

The characterisation and determinants of quality of life in ANCA associated vasculitis
od: Basu, N, i dr.
Izdano: (2014)

Opinion: Maintenance of clinical remission in ANCA-associated vasculitis
od: Luqmani, R
Izdano: (2013)

Determinants of Poor Quality of Life in ANCA Associated Vasculitis (AAV).
od: Basu, N, i dr.
Izdano: (2012)

Cutaneous manifestations of ANCA-associated vasculitis
od: Chiesafuxench, Z, i dr.
Izdano: (2016)

Cardiovascular outcomes in ANCA associated vasculitis
od: Mukhtyar, C, i dr.
Izdano: (2008)

Markers for work disability in ANCA-associated vasculitis
od: Basu, N, i dr.
Izdano: (2013)

Diagnosis and management of ANCA associated vasculitis.
od: Berden, A, i dr.
Izdano: (2012)

USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (VERSION 3) FOR DIAGNOSING VASCULITIS
od: Mukhtyar, C, i dr.
Izdano: (2009)

Treatment of renal manifestations of ANCA-associated vasculitis
od: Kresimir Galesic, i dr.
Izdano: (2013-01-01)

Renal thrombotic microangiopathy in an ANCA-associated vasculitis
od: Ana Teresa Domingos, i dr.
Izdano: (2019-10-01)

The need for diagnostic criteria in systemic vasculitis
od: Suppiah, R, i dr.
Izdano: (2011)

ANCA-associated vasculitis: Where can we go from here?
od: Luqmani, R
Izdano: (2010)

Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients.
od: Arnold, D, i dr.
Izdano: (2010)

Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS
od: Jones, R, i dr.
Izdano: (2009)

Clinical features and outcomes of ANCA-associated renal vasculitis
od: Sidy Mohamed Seck, i dr.
Izdano: (2012-01-01)

Diagnosis and assessment of systemic vasculitis.
od: McLaren, J, i dr.
Izdano: (2002)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
od: Suppiah, R, i dr.
Izdano: (2011)

Long-term survival of ANCA-associated vasculitis
od: Flossmann, O, i dr.
Izdano: (2009)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
od: T. V. Beketova
Izdano: (2023-10-01)

Pulmonary involvement of ANCA-associated vasculitis in adult Chinese patients
od: Peining Zhou, i dr.
Izdano: (2022-01-01)

Global ethnic and geographic idfferences in the clinical features of ANCA-associated vasculitis
od: Pearce, F, i dr.
Izdano: (2016)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
od: Suppiah, R, i dr.
Izdano: (2011)

Comparison of disease activity measures for ANCA-associated vasculitis.
od: Merkel, P, i dr.
Izdano: (2004)